Applied DNA Sciences Inc (APDN)
0.2887
-0.04
(-12.52%)
USD |
NASDAQ |
Apr 23, 16:00
0.319
+0.03
(+10.50%)
After-Hours: 20:00
Applied DNA Sciences Revenue (TTM): 8.996M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.996M |
| September 30, 2023 | 13.37M |
| June 30, 2023 | 16.15M |
| March 31, 2023 | 17.53M |
| December 31, 2022 | 19.27M |
| September 30, 2022 | 18.17M |
| June 30, 2022 | 17.65M |
| March 31, 2022 | 15.05M |
| December 31, 2021 | 11.58M |
| September 30, 2021 | 9.028M |
| June 30, 2021 | 6.302M |
| March 31, 2021 | 5.033M |
| December 31, 2020 | 2.914M |
| September 30, 2020 | 1.932M |
| June 30, 2020 | 3.290M |
| March 31, 2020 | 4.912M |
| December 31, 2019 | 5.138M |
| September 30, 2019 | 5.389M |
| June 30, 2019 | 4.912M |
| March 31, 2019 | 3.874M |
| December 31, 2018 | 4.14M |
| September 30, 2018 | 3.903M |
| June 30, 2018 | 3.854M |
| March 31, 2018 | 4.634M |
| December 31, 2017 | 4.496M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.751M |
| June 30, 2017 | 5.242M |
| March 31, 2017 | 4.097M |
| December 31, 2016 | 3.765M |
| September 30, 2016 | 4.186M |
| June 30, 2016 | 6.531M |
| March 31, 2016 | 8.145M |
| December 31, 2015 | 9.091M |
| September 30, 2015 | 9.008M |
| June 30, 2015 | 5.674M |
| March 31, 2015 | 4.247M |
| December 31, 2014 | 3.366M |
| September 30, 2014 | 2.721M |
| June 30, 2014 | 2.805M |
| March 31, 2014 | 2.608M |
| December 31, 2013 | 2.316M |
| September 30, 2013 | 2.036M |
| June 30, 2013 | 1.598M |
| March 31, 2013 | 1.482M |
| December 31, 2012 | 1.656M |
| September 30, 2012 | 1.855M |
| June 30, 2012 | 1.845M |
| March 31, 2012 | 1.546M |
| December 31, 2011 | 1.168M |
| September 30, 2011 | 0.9688M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.932M
Minimum
Sep 2020
19.27M
Maximum
Dec 2022
9.821M
Average
8.996M
Median
Dec 2023
Revenue (TTM) Benchmarks
| Fonar Corp | 102.42M |
| XWELL Inc | 30.11M |
| ProPhase Labs Inc | 44.38M |
| Veracyte Inc | 361.05M |
| OncoCyte Corp | 1.503M |